The Problem Rotator cuff repair results in predictable pain relief and a variable return of function in the majority of patients. However, it may take up to a year to achieve maximum improvement in shoulder strength and function. In certain cases patients may continue to experience pain and weakness in the shoulder following rotator cuff…
Treatment with single-agent ibrutinib was well-tolerated and provided durable responses in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
For the treatment of patients with advanced urothelial cancer, pembrolizumab demonstrated anti-tumor activity and an acceptable safety profile.
Treatment with diagnostic laparoscopy rather than primary surgery may lower the rate of futile laparotomies among women with suspected advanced ovarian cancer.
Those of Asian ethnicity have superior median overall and PCa-specific survival to men of any other race.
Diarrhea is a common but manageable side effect for patients with HER2-positive breast cancer undergoing treatment with pertuzumab.
For relapsed or refractory diffuse large B-cell lymphoma (DLBCL), there is no difference in efficacy between ofatumumab or rituximab.
Several factors are predictive of skeletal-related events (SREs) among patients being treated for bone metastatic castration-resistant prostate cancer (mCRPC).
An immediate 1-stage IBBR with use of ADMs after mastectomy may carry a higher risk for complications compared to 2-stage IBBR.
Among African-American women, the 10-year probability estimate for the development of TNBC was 0.56% compared to 0.25% among Caucasian women.
